26 results

• Prolia Fracture Risk Leads Public Citizen to Call For Black Box Warning

  April 19, 2019

  Irvin Jackson

  Public Citizen is calling for more stringent warnings on the osteoporosis drug Prolia, saying it is linked to an increased risk of vertebral fractures once patients stop using it.

• Kyprolis Side Effects May Increase Risks of Heart Problems, Researchers Warn

  January 2, 2018

  Irvin Jackson

  A new study warns that Kyprolis heart problems may be more widespread than previously believed.

• Repatha, Similar Cholesterol Drugs, Overpriced For Benefits They Provide: Study

  August 25, 2017

  Irvin Jackson

  A new class of cholesterol drugs that includes Repatha and Praluent may be significantly overpriced in the U.S. when you look at the benefits they provide, according to the findings of a new study.

• Aranesp Stevens-Johnson Syndrome Warning Issued By Canadian Health Officials

  May 19, 2017

  Irvin Jackson

  The anemia drug Aranesp appears to be linked to cases of severe and potentially life-threatening skin reactions, according to a new warning by Canadian health officials.

• Prolia and Xgeva Side Effects May Include Heart Rhythm Risks, Australia Warns

  August 17, 2016

  Irvin Jackson

  Australian regulators warn that the side effects of the bone drugs Prolia and Xgeva can result in abnormal heart rhythms.

• Praluent, Repatha Costs Outweigh Health Benefits: Study

  September 14, 2015

  Irvin Jackson

  A new report warns that the cholesterol drugs Praluent and Repatha may be too expensive for the modest benefits they give to patients.

• Enbrel Schizophrenia Symptoms Reviewed by Health Canada

  September 11, 2015

  Irvin Jackson

  Health Canada could find no link between Enbrel and an increased risk of schizophrenia following a safety review.

• Prolia Side Effects Increase Risk of Low-Trauma Fractures: Public Citizen

  June 7, 2013

  Irvin Jackson

  A prominent consumer watchdog group is warning that Prolia could increase the risk of sudden bone fractures.

• For-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study

  May 17, 2013

  Irvin Jackson

  Even after the FDA warned that anemia drugs like Aranesp, Epogen and Procrit could increase the risk of death among...

• FDA Halts Pediatric Trials for Sensipar After Teen’s Death

  February 27, 2013

  Irvin Jackson

  Following the death of a 14-year-old test subject, federal health regulators have forced Amgen to halt pediatric trials of the...